Skip to content

Rosuvastatin and 10-week resistance band exercises for obese individuals of Multan

Comparative effects of rosuvastatin and 10-week resistance band exercises for obese individuals of Multan

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230202057310N15
Enrollment
380
Registered
2024-12-27
Start date
2025-01-06
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Overweight and obesity

Interventions

Intervention 1: Intervention group: Group 1: Participants in the drug intervention group will receive e.g., Rosuvastatin 5mg administered orally once daily. This medication has been selected based on

Sponsors

Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Adults aged 18-65 years • Diagnosed with dyslipidemia, defined as elevated levels of total cholesterol (=200 mg/dL) Able and willing to adhere to either drug therapy or a structured exercise program LDL cholesterol (=130 mg/dL) Triglycerides (=150 mg/dL) ow HDL cholesterol (<40 mg/dL for men, <50 mg/dL for women)

Exclusion criteria

Exclusion criteria: History of cardiovascular diseases (e.g., myocardial infarction, angina) Uncontrolled hypertension (=160/100 mmHg) Conditions contraindicating exercise (e.g., musculoskeletal disorders) Recent history of smoking or current tobacco use Current use of lipid-lowering drugs or recent participation in a structured exercise program Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Lipid profile parameters (total cholesterol, LDL, HDL, and triglycerides). Timepoint: 10 weeks. Method of measurement: Blood sample.;Body mass index. Timepoint: 10 weeks. Method of measurement: Calculated from weight and height (measured using a digital scale and stadiometer).

Secondary

MeasureTime frame
Blood pressure. Timepoint: 10 weeks. Method of measurement: Measured using a calibrated sphygmomanometer after a 5-minute rest in a seated position.;Waist-to-Hip Ratio, Hip to knee ration and Hip circumference. Timepoint: 10 weeks. Method of measurement: Assessed using a flexible measuring tape.;Quality of life. Timepoint: 10 weeks. Method of measurement: SF-36.

Countries

Pakistan

Contacts

Public ContactMaliha Khalid Khan

Muhammad Institute of Medical and Allied Sciences, Multan, Pakistan.

malihatareen1997@gmail.com+92 312 6827130

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026